Fraud Detection and Prevention Market to Reach USD 153.91 Billion by 2030, Driven by Real-Time Analytics and AI IntegrationJuly 6, 2025
The Viking therapeutics executive is selling shares worth more than $715,000 by Investing.comSeptember 23, 20240 Viking Therapeutics, Inc. (NASDAQ:) director J. Matthew Singleton conducted a sale of company stock worth more than $715,000, according to…
Viking Therapeutics CEO Sells More Than $15 Million in Company Stock by Investing.comSeptember 23, 20240 Brian Lian, the president and CEO of Viking Therapeutics, Inc. (NASDAQ:), has sold a significant portion of its company’s stock,…